Publications by authors named "Matthieu Duchmann"

Claim this Profile
A
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies.
Michael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, Marie-Mathilde Auboiroux, Nathalie Gachard, Matthieu Duchmann

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myelomonocytic leukaemia occurring in patients with pulmonary Langerhans cell histiocytosis: A common progenitor?
Pierre Thoré, Sérine Chaibi, Matthieu Duchmann, Raphaël Itzykson, Amira Benattia

Respir Med Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine.
Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette, Lorea Aguinaga, Arij Cheffai, Matthieu Duchmann

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet Syndrome.
Chloé Grolleau, Maxime Battistella, Eve Zakine, Thomas Poisot, Florence Cordoliani, Matthieu Duchmann

JAMA Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell sequencing applications in acute myeloid leukemia.
Nicolas Lecornec, Matthieu Duchmann, Raphael Itzykson

Leuk Lymphoma· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients.
Adriane Halik, Marlon Tilgner, Patricia Silva, Natalia Estrada, Robert Altwasser, Matthieu Duchmann

J Hematol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.
Lois M Kelly, Justine C Rutter, Kevin H Lin, Frank Ling, Matthieu Duchmann

Nat Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.
Marie Sébert, Lucie Freiman, Cendrine Chaffaut, Agnès Guerci, Pierre Peterlin, Matthieu Duchmann

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline CHEK2 mutations in patients with myeloid neoplasms.
Lucie Freiman, Lise Larcher, Giulia Tueur, Nadia Vasquez, Mélanie Da Costa, Matthieu Duchmann

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
Rathana Kim, Hugo Bergugnat, Lise Larcher, Matthieu Duchmann, Marie Passet

Blood Cancer Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.
Marie Sebert, Stéphanie Gachet, Thierry Leblanc, Alix Rousseau, Olivier Bluteau, Matthieu Duchmann

Cell Stem Cell· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, Matthieu Duchmann

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
Augustin Boudry, Sasha Darmon, Nicolas Duployez, Martin Figeac, Sandrine Geffroy, Matthieu Duchmann

BMC Bioinformatics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
Augustin Boudry, Sasha Darmon, Nicolas Duployez, Martin Figeac, Sandrine Geffroy, Matthieu Duchmann

BMC Bioinformatics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.
Matthieu Duchmann, Romane Joudinaud, Augustin Boudry, Justine Pasanisi, Giuseppe Di Feo

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, Rathana Kim, Julie Rieunier

Blood· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Bryann Pardieu, Justine Pasanisi, Frank Ling, Reinaldo Dal Bello, Justine Penneroux, Matthieu Duchmann

Leukemia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Reinaldo Dal Bello, Justine Pasanisi, Romane Joudinaud, Matthieu Duchmann, Bryann Pardieu

Blood Cancer J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.
Matthieu Duchmann, Orianne Wagner-Ballon, Thomas Boyer, Meyling Cheok, Elise Fournier

Leukemia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers.
Sabine Khalife-Hachem, Khalil Saleh, Florence Pasquier, Christophe Willekens, Anthony Tarabay, Matthieu Duchmann

Hemasphere· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias.
Matthieu Duchmann, Lucie Laplane, Raphael Itzykson

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.
Matthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, Emmanuel Raffoux, Xavier Thomas

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.
Marco Cerrano, Matthieu Duchmann, Rathana Kim, Loic Vasseur, Pierre Hirsch

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.
Matthieu Jestin, Sihem Tarfi, Matthieu Duchmann, Bouchra Badaoui, Nicolas Freynet

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High effector-memory CD8 T-cell levels correlate with high PML risk in natalizumab-treated patients.
Asma Beldi-Ferchiou, Abir Wahab, Matthieu Duchmann, Jérôme Hodel, Ivania Patry

Mult Scler Relat Disord· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis